NTRK1 and central nervous system cancer: PDGFRA is an important receptor tyrosine kinase in glial development and a recurrent driver in high-grade gliomas [7–9] PDGFRA mutation and the PDGFRA signaling pathway were reported to play potent oncogenic roles in G34-DHGs [10].